RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BOYER M
Collezione AOU San Luigi di Orbassano

Items : 5

5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death Ligand 1-Positive Advanced Non-Small-Cell Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 May 25:S1556-0864(21)02172-9. doi: 10.1016/j.jtho.2021.05.001.

2021
AOU San Luigi di Orbassano

Herbst RS; Garon EB; Kim DW; Cho BC; Gervais R; Perez-Gracia JL; Han JY; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su WC; Samkari A; Jensen EH; Kobie J; Piperdi B; Baas P;

FP13.01 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC in Journal of Thoracic Oncology

2021
AOU San Luigi di Orbassano

Herbst R; Garon E; Kim D; Cho BC; Gervais R; Perez-Gracia JL; Han J; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su W; Samkari A; Jensen EH; Piperdi B; Baas P;

Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1505-1517. doi: 10.1200/JCO.19.03136. Epub 2020 Mar 9.

2020
AOU San Luigi di Orbassano

Novello S; Rubio-Viqueira B; Garon EB; Reck M; Jennens RR; Grossi F; Peled N; Bischoff HG; Cheng SY; Powell SF; Clingan P; Hochmair MJ; Hui R; Dómine M; Felip E; Esteban E; Speranza G; Gadgeel S; Rodríguez-Abreu D; Boyer M; Kurata T; Gray JE; Yang J; Bas T; Pietanza MC; Garassino MC;

Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. in The New England journal of medicine / N Engl J Med. 2018 May 31;378(22):2078-2092. doi: 10.1056/NEJMoa1801005. Epub 2018 Apr 16.

2018
AOU San Luigi di Orbassano

Gandhi L; Rodríguez-Abreu D; Gadgeel S; Esteban E; Felip E; De Angelis F; Domine M; Clingan P; Hochmair MJ; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Hui R; Garon EB; Boyer M; Rubio-Viqueira B; Novello S; Kurata T; Gray JE; Vida J; Wei Z; Yang J; Raftopoulos H; Pietanza MC; Garassino MC; et alii...

Efficacy and Safety of Onartuzumab in Combination With First-Line Bevacizumab- or Pemetrexed-Based Chemotherapy Regimens in Advanced Non-Squamous Non-Small-Cell Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):50-59. doi: 10.1016/j.cllc.2016.09.013. Epub 2016 Oct 19.

2017
AOU San Luigi di Orbassano

Wakelee H; Zvirbule Z; De Braud F; Kingsley CD; Mekhail T; Lowe T; Schütte W; Lena H; Lawler W; Braiteh F; Cosgriff T; Kaen D; Boyer M; Hsu J; Phan S; Novello S;